The Consortium for Genomics & Therapeutics in Africa (CGTA) has been established by the African Institute of Biomedical Science and Technology (AiBST) as a mechanism to implement its Bill and Melinda Gates (BMGF) Calestous Juma (CJ) Research Leadership award to Prof. Collen Masimirembwa. The two main aims of the award being to establish a drug discovery ecosystem and to expand pharmacogenomic testing for improved health in Africa. CGTA is a research network that aims to create an ecosystem for translational research in genomics and therapeutics to deliver healthcare solutions for Africa.
To build capacity for bioanalytics, genomics, bioinformatics and pharmacometrics to support translational science at selected Centers of Excellence (CoE) in Africa through establishing advanced technology platforms and training highly skilled scientists.
To harness Africa’s genomic diversity in health research and innovation for drugs, vaccines, diagnostics and medical devices.
To expand the clinical application of pharmacogenomics through these CoE.
African Institute of Biomedical Science and Technology (AiBST), Zimbabwe
African Institute of Biomedical Science and Technology (AiBST), Zimbabwe
Learn more about the Consortium for Genomics & Therapeutics in Africa (CGTA) Team
The Consortium for Genomics & Therapeutics in Africa (CGTA) has been established
by the African Institute of Biomedical Science and Technology (AiBST)
Get The Latest Updates via email. Any time you may unsubscribe
